Literature DB >> 17644171

Radiopaque iodinated polymeric nanoparticles for X-ray imaging applications.

Anna Galperin1, David Margel, Jack Baniel, Gillian Dank, Hagit Biton, Shlomo Margel.   

Abstract

Iodinated radiopaque polymeric nanoparticles of sizes ranging between 30 and 350 nm were formed by emulsion polymerization of the monomer 2-methacryloyloxyethyl(2,3,5-triiodobenzoate) in the presence of sodium dodecyl sulfate as surfactant and potassium persulfate as initiator. The influence of various polymerization parameters, e.g., monomer, initiator and surfactant concentrations on the molecular weight, polymerization yield, size and size distribution of the particles was elucidated. Characterization of these iodinated nanoparticles was accomplished by routine methods such as FTIR, 1H NMR, TEM, TGA, DSC, GPC and light scattering. These polymeric nanoparticles are composed of ca. 58% by weight iodine, and are therefore expected to possess significant radiopaque nature. In vitro radiopacity of the iodinated nanoparticles of 30.6+/-5.0 nm diameter, dispersed in water and in the dry state, was demonstrated with a CT scanner. In vivo CT-imaging performed in a dog model by intravenous administration of the uniform 30.6+/-5.0 nm diameter radiopaque nanoparticles dispersed in saline demonstrated significant enhanced visibility of lymph nodes, liver, kidney and spleen. These results indicate that these nanoparticles may be useful as new efficient contrast agents for X-ray imaging applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644171     DOI: 10.1016/j.biomaterials.2007.06.032

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  19 in total

Review 1.  Molecular body imaging: MR imaging, CT, and US. part I. principles.

Authors:  Moritz F Kircher; Jürgen K Willmann
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

Review 2.  Preclinical lymphatic imaging.

Authors:  Fan Zhang; Gang Niu; Guangming Lu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

Review 3.  Nanotechnology for computed tomography: a real potential recently disclosed.

Authors:  Nicolas Anton; Thierry F Vandamme
Journal:  Pharm Res       Date:  2013-07-30       Impact factor: 4.200

4.  Poly(ethylene glycol)-poly(ε-caprolactone) iodinated nanocapsules as contrast agents for X-ray imaging.

Authors:  François Hallouard; Stéphanie Briançon; Nicolas Anton; Xiang Li; Thierry Vandamme; Hatem Fessi
Journal:  Pharm Res       Date:  2013-04-26       Impact factor: 4.200

5.  Zr- and Hf-based nanoscale metal-organic frameworks as contrast agents for computed tomography.

Authors:  Kathryn E Dekrafft; William S Boyle; Laurel M Burk; Otto Z Zhou; Wenbin Lin
Journal:  J Mater Chem       Date:  2012-06-07

Review 6.  X-ray-computed tomography contrast agents.

Authors:  Hrvoje Lusic; Mark W Grinstaff
Journal:  Chem Rev       Date:  2012-12-05       Impact factor: 60.622

7.  Review of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores and Multifunctional Nano Carriers.

Authors:  Vikram Pansare; Shahram Hejazi; William Faenza; Robert K Prud'homme
Journal:  Chem Mater       Date:  2012-01-11       Impact factor: 9.811

Review 8.  Nanoparticles for biomedical imaging.

Authors:  Satish K Nune; Padmaja Gunda; Praveen K Thallapally; Ying-Ying Lin; M Laird Forrest; Cory J Berkland
Journal:  Expert Opin Drug Deliv       Date:  2009-11       Impact factor: 6.648

Review 9.  In vivo small animal micro-CT using nanoparticle contrast agents.

Authors:  Jeffrey R Ashton; Jennifer L West; Cristian T Badea
Journal:  Front Pharmacol       Date:  2015-11-04       Impact factor: 5.810

10.  Freeform fabrication of tissue-simulating phantom for potential use of surgical planning in conjoined twins separation surgery.

Authors:  Shuwei Shen; Haili Wang; Yue Xue; Li Yuan; Ximing Zhou; Zuhua Zhao; Erbao Dong; Bin Liu; Wendong Liu; Barrett Cromeens; Brent Adler; Gail Besner; Ronald X Xu
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.